In particular, in a scenario where LDL receptor roles are clear in the cholesterol metabolism and in the amyloidosis, given their interaction with APP, the corresponding roles of the purinergic receptors need to be further clarified. This evidence concerns the gene P2RY1 and amyloidosis.